Cargando…

Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report

BACKGROUND: Eosinophilia is defined as a blood eosinophil count > 500/mcL with etiology usually an allergic reaction or parasitic infection which can lead to serious organ damage. CASE PRESENTATION: A patient being treated for hardware infection develops eosinophilia while on daptomycin in the se...

Descripción completa

Detalles Bibliográficos
Autores principales: Eckhardt, Lynda G. J., Kelley, Jordan L., Maes, Dorothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682830/
https://www.ncbi.nlm.nih.gov/pubmed/36418971
http://dx.doi.org/10.1186/s12879-022-07852-y
_version_ 1784834942034771968
author Eckhardt, Lynda G. J.
Kelley, Jordan L.
Maes, Dorothy
author_facet Eckhardt, Lynda G. J.
Kelley, Jordan L.
Maes, Dorothy
author_sort Eckhardt, Lynda G. J.
collection PubMed
description BACKGROUND: Eosinophilia is defined as a blood eosinophil count > 500/mcL with etiology usually an allergic reaction or parasitic infection which can lead to serious organ damage. CASE PRESENTATION: A patient being treated for hardware infection develops eosinophilia while on daptomycin in the setting of a positive strongyloides antibody. The patient was on chronic steroids prior to admission for epitheliopathy which complicated care. The daptomycin was discontinued, ivermectin initiated to treat strongyloidiasis, and high dose steroids initiated simultaneously. Eosinophilia resolved and patient discharged home after two months in the hospital. CONCLUSION: Multifactorial eosinophilia poses question of steroid harm in the setting of parasitic infection. Patient was treated for both strongyloides and daptomycin induced eosinophilia with improvement and discharge from the hospital.
format Online
Article
Text
id pubmed-9682830
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96828302022-11-24 Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report Eckhardt, Lynda G. J. Kelley, Jordan L. Maes, Dorothy BMC Infect Dis Case Report BACKGROUND: Eosinophilia is defined as a blood eosinophil count > 500/mcL with etiology usually an allergic reaction or parasitic infection which can lead to serious organ damage. CASE PRESENTATION: A patient being treated for hardware infection develops eosinophilia while on daptomycin in the setting of a positive strongyloides antibody. The patient was on chronic steroids prior to admission for epitheliopathy which complicated care. The daptomycin was discontinued, ivermectin initiated to treat strongyloidiasis, and high dose steroids initiated simultaneously. Eosinophilia resolved and patient discharged home after two months in the hospital. CONCLUSION: Multifactorial eosinophilia poses question of steroid harm in the setting of parasitic infection. Patient was treated for both strongyloides and daptomycin induced eosinophilia with improvement and discharge from the hospital. BioMed Central 2022-11-22 /pmc/articles/PMC9682830/ /pubmed/36418971 http://dx.doi.org/10.1186/s12879-022-07852-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Eckhardt, Lynda G. J.
Kelley, Jordan L.
Maes, Dorothy
Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title_full Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title_fullStr Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title_full_unstemmed Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title_short Challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
title_sort challenges in managing a multifactorial eosinophilic pneumonia: daptomycin vs strongyloidiasis case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682830/
https://www.ncbi.nlm.nih.gov/pubmed/36418971
http://dx.doi.org/10.1186/s12879-022-07852-y
work_keys_str_mv AT eckhardtlyndagj challengesinmanagingamultifactorialeosinophilicpneumoniadaptomycinvsstrongyloidiasiscasereport
AT kelleyjordanl challengesinmanagingamultifactorialeosinophilicpneumoniadaptomycinvsstrongyloidiasiscasereport
AT maesdorothy challengesinmanagingamultifactorialeosinophilicpneumoniadaptomycinvsstrongyloidiasiscasereport